AU6527390A - Pharmaceutical compositions for the treatment of ataxy and equilibrium problems - Google Patents

Pharmaceutical compositions for the treatment of ataxy and equilibrium problems

Info

Publication number
AU6527390A
AU6527390A AU65273/90A AU6527390A AU6527390A AU 6527390 A AU6527390 A AU 6527390A AU 65273/90 A AU65273/90 A AU 65273/90A AU 6527390 A AU6527390 A AU 6527390A AU 6527390 A AU6527390 A AU 6527390A
Authority
AU
Australia
Prior art keywords
ataxy
treatment
pharmaceutical compositions
equilibrium problems
equilibrium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65273/90A
Inventor
Paul Trouillas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6527390A publication Critical patent/AU6527390A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU65273/90A 1989-11-24 1990-09-27 Pharmaceutical compositions for the treatment of ataxy and equilibrium problems Abandoned AU6527390A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8915757A FR2654931B1 (en) 1989-11-24 1989-11-24 PHARMACEUTICAL COMPOSITIONS HAVING ACTIVITY ON ATAXIA AND BALANCE DISORDERS, CEREBELLOUS OR OTHER, OF ALL ORIGINS, COMPRISING THE ASSOCIATION OF L-5-HYDROXYTRYPTOPHANE AND CARBIDOPA.
FR8915757 1989-11-24

Publications (1)

Publication Number Publication Date
AU6527390A true AU6527390A (en) 1991-06-26

Family

ID=9387947

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65273/90A Abandoned AU6527390A (en) 1989-11-24 1990-09-27 Pharmaceutical compositions for the treatment of ataxy and equilibrium problems

Country Status (3)

Country Link
AU (1) AU6527390A (en)
FR (1) FR2654931B1 (en)
WO (1) WO1991007960A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004039196B4 (en) 2004-08-12 2008-07-31 Dr.Kamprad Kg New formulation for L-tryptophan
IL276059B1 (en) * 2018-01-29 2024-04-01 Univ Duke Compositions and methods of enhancing 5-hydroxytryptophan bioavailability
EP3593819A1 (en) 2018-07-10 2020-01-15 Medday Pharmaceuticals Compositions for therapeutic uses containing 5-htp and carbidopa
US11752107B2 (en) 2021-07-30 2023-09-12 Evecxia Therapeutics, Inc. 5-hydroxytryptophan gastroretentive dosage forms
EP4392031A1 (en) 2021-10-14 2024-07-03 Evecxia Therapeutics, Inc. A method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes
DE102022103658A1 (en) 2022-02-16 2023-08-17 Joachim Kamprad Drug composition containing L-tryptophan (L-Try) and L-5-hydroxytryptophan (5-HTP) and a peripheral degradation inhibitor
WO2024148354A1 (en) * 2023-01-06 2024-07-11 Evecxia Therapeutics, Inc. A method of enhancing 5-hydroxytryptophan (5-htp) exposure

Also Published As

Publication number Publication date
FR2654931B1 (en) 1993-08-27
FR2654931A1 (en) 1991-05-31
WO1991007960A1 (en) 1991-06-13

Similar Documents

Publication Publication Date Title
HU896480D0 (en) Process for the preparation of dipeptidecarbamide derivatives inhibiting enzymes and pharmaceutical compositions thereof
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
HU896428D0 (en) Process for the preparation of imidazoles and pharmaceutical compositions thereof
AU2951489A (en) Improving the stability of pharmaceutical compositions
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
NZ228222A (en) 2(substituted-1-tetrahydropyridyl or substituted piperazinyl) propyl: isoindolinone derivatives; preparatory processes and pharmaceutical compositions
HU896479D0 (en) Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof
HU896612D0 (en) Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof
AU8316587A (en) Pharmaceutical compositions and their use
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
IL96747A0 (en) Oxazole derivatives and pharmaceutical compositions containing them
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
HU896022D0 (en) Process for the preparation of substituted pyrazoles and pharmaceutical compositions thereof
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
EP0362162A3 (en) Pharmaceutical composition comprising zidovudine and inosiplex or components thereof for the treatment of aids and aids-related syndromes
HU895948D0 (en) Process for the preparation of dipeptidecarbamide derivatives having inhibition of renine and pharmaceutical compositions thereof
HU895817D0 (en) Process for the preparation of phenyloxy-propanol-amine derivatives and pharmaceutical compositions containing them
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes